222 related articles for article (PubMed ID: 24293464)
21. The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension.
Kabitz HJ; Bremer HC; Schwoerer A; Sonntag F; Walterspacher S; Walker DJ; Ehlken N; Staehler G; Windisch W; Grünig E
Lung; 2014 Apr; 192(2):321-8. PubMed ID: 24338088
[TBL] [Abstract][Full Text] [Related]
22. One-year experience with intravenous treprostinil for pulmonary arterial hypertension.
Benza RL; Tapson VF; Gomberg-Maitland M; Poms A; Barst RJ; McLaughlin VV
J Heart Lung Transplant; 2013 Sep; 32(9):889-96. PubMed ID: 23953817
[TBL] [Abstract][Full Text] [Related]
23. Treatment goals of pulmonary hypertension.
McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
[TBL] [Abstract][Full Text] [Related]
24. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
[TBL] [Abstract][Full Text] [Related]
25. Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.
Gerhardt F; Dumitrescu D; Gärtner C; Beccard R; Viethen T; Kramer T; Baldus S; Hellmich M; Schönau E; Rosenkranz S
Heart; 2017 Apr; 103(8):592-598. PubMed ID: 28100544
[TBL] [Abstract][Full Text] [Related]
26. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA
Respir Med; 2022 May; 196():106801. PubMed ID: 35316723
[TBL] [Abstract][Full Text] [Related]
27. The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension.
Lee WT; Peacock AJ; Johnson MK
Eur Respir J; 2010 Dec; 36(6):1294-301. PubMed ID: 20351027
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.
Harari S; Caminati A; Cassandro R; Conti S; Madotto F; Luisi F; Cesana G
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):297-305. PubMed ID: 25591141
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
Frost AE; Badesch DB; Miller DP; Benza RL; Meltzer LA; McGoon MD
Chest; 2013 Nov; 144(5):1521-1529. PubMed ID: 23907471
[TBL] [Abstract][Full Text] [Related]
30. A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.
Elinoff JM; Rame JE; Forfia PR; Hall MK; Sun J; Gharib AM; Abd-Elmoniem K; Graninger G; Harper B; Danner RL; Solomon MA
Trials; 2013 Apr; 14():91. PubMed ID: 23547564
[TBL] [Abstract][Full Text] [Related]
31. Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension.
Moutchia J; McClelland RL; Al-Naamani N; Appleby DH; Blank K; Grinnan D; Holmes JH; Mathai SC; Minhas J; Ventetuolo CE; Zamanian RT; Kawut SM
Am J Respir Crit Care Med; 2023 Apr; 207(8):1070-1079. PubMed ID: 36629737
[No Abstract] [Full Text] [Related]
32. End points and clinical trial design in pulmonary arterial hypertension.
McLaughlin VV; Badesch DB; Delcroix M; Fleming TR; Gaine SP; Galiè N; Gibbs JSR; Kim NH; Oudiz RJ; Peacock A; Provencher S; Sitbon O; Tapson VF; Seeger W
J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S97-S107. PubMed ID: 19555863
[TBL] [Abstract][Full Text] [Related]
33. BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis.
McCarthy BE; McClelland RL; Appleby DH; Moutchia JS; Minhas JK; Min J; Mazurek JA; Smith KA; Fritz JS; Pugliese SC; Urbanowicz RJ; Holmes JH; Palevsky HI; Kawut SM; Al-Naamani N
Chest; 2022 Aug; 162(2):436-447. PubMed ID: 35247393
[TBL] [Abstract][Full Text] [Related]
34. End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
Peacock AJ; Naeije R; Galiè N; Rubin L
Eur Respir J; 2009 Jul; 34(1):231-42. PubMed ID: 19567606
[TBL] [Abstract][Full Text] [Related]
35. Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials.
Ventetuolo CE; Moutchia J; Baird GL; Appleby DH; McClelland RL; Minhas J; Min J; Holmes JH; Urbanowicz RJ; Al-Naamani N; Kawut SM
Ann Am Thorac Soc; 2023 Jan; 20(1):58-66. PubMed ID: 36053665
[No Abstract] [Full Text] [Related]
36. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension.
Leuchte HH; Holzapfel M; Baumgartner RA; Neurohr C; Vogeser M; Behr J
Chest; 2005 Oct; 128(4):2368-74. PubMed ID: 16236896
[TBL] [Abstract][Full Text] [Related]
37. Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension.
Provencher S; Chemla D; Hervé P; Sitbon O; Humbert M; Simonneau G
Eur Respir J; 2006 Jan; 27(1):114-20. PubMed ID: 16387943
[TBL] [Abstract][Full Text] [Related]
38. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
Gomberg-Maitland M; Huo D; Benza RL; McLaughlin VV; Tapson VF; Barst RJ
J Heart Lung Transplant; 2007 Jul; 26(7):732-8. PubMed ID: 17613405
[TBL] [Abstract][Full Text] [Related]
39. Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis.
Faisal M; Siddiqi F; Alkaddour A; Bajwa AA; Shujaat A
Pulm Med; 2014; 2014():528783. PubMed ID: 25478223
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension.
Chaouat A; Sitbon O; Mercy M; Ponçot-Mongars R; Provencher S; Guillaumot A; Gomez E; Selton-Suty C; Malvestio P; Regent D; Paris C; Hervé P; Chabot F
Eur Respir J; 2014 Sep; 44(3):704-13. PubMed ID: 24833765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
